Haemoglobin targets: we were wrong, time to move on.
Strippoli
Giovanni F M
GF
Cochrane Renal Group and Centre for Kidney Research and NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Sydney, New South Wales, Australia. strippoli@negrisud.it
Tognoni
Giovanni
G
Navaneethan
Sankar D
SD
Nicolucci
Antonio
A
Craig
Jonathan C
JC
D000740:Anemia / Q000150:complications / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006454:Hemoglobins / Q000187:drug effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D012306:Risk
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin